Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States

Cost Effectiveness and Resource Allocation

Volumn 6, Issue , 2008, Pages

  Chesson, Harrell W ^a   Collins, Dayne ^a   Koski, Kathryn ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ARTICLE; CHLAMYDIASIS; CONGENITAL SYPHILIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COUNSELING; EVIDENCE BASED MEDICINE; FEMALE; GONORRHEA; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PELVIC INFLAMMATORY DISEASE; PROBABILITY; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; UNITED STATES; VIRUS TRANSMISSION;

EID: 45549106713     PISSN: None     EISSN: 14787547     Source Type: Journal    
DOI: 10.1186/1478-7547-6-10     Document Type: Article

References (95)

1. Chesson HW Gift TL Pulver ALS The economic value of reductions in gonorrhea and syphilis incidence in the United States, 1990-2003 Prev Med 2006, 43:411-415. 10.1016/j.ypmed.2006.06.013 16901533
2. Weinstock H Berman S Cates Jr. W Sexually transmitted diseases in American youth: Incidence and prevalence estimates Perspect Sex Reprod Health 2004, 36:6-10. 10.1363/3600604 14982671
3. Siegel JE Estimates of the economic burden of STDs: Review of the literature with updates The Hidden Epidemic: Confronting Sexually Transmitted Diseases Washington, DC, National Academy Press Eng TR and Butler WT 1997, 330-356.
4. Association ASH Sexually Transmitted Diseases in America: How Many Cases and at What Cost? Menlo Park, CA, Kaiser Family Foundation Alexander LL, Cates JR, Herndon N and Ratcliffe JF 1998
5. Chesson HW Blandford JM Gift TL Tao G Irwin KL The estimated direct medical cost of sexually transmitted diseases among American youth, 2000. Perspect Sex Reprod Health 2004, 36:11-19. 10.1363/3601104 14982672
6. Hutchinson AB Farnham PG Dean HD Ekwueme DU del Rio C Kamimoto L Kellerman SE The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: Evidence of continuing racial and ethnic differences J Acquir Immune Defic Syndr 2006, 43:451-457. 10.1097/01.qai.0000243090.32866.4e 16980906
7. Control CD Cost-benefit ratios of prevention STD-HIV Interchange Atlanta, GA, Centers for Disease Control 1992
8. Gold MR Siegal JE Russell LB Weinstein MC Cost-Effectiveness in Health and Medicine New York, Oxford University Press Gold MR, Siegal JE, Russell LB and Weinstein MC 1996
9. Haddix AC Teutsch SM Corso PS Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation New York, Oxford University Press Haddix AC, Teutsch SM and Corso PS 2nd 2002
10. Washington AE Johnson RE Sanders LL Jr. Chlamydia trachomatis infections in the United States: What are they costing us? JAMA 1987, 257:2070-2072. 10.1001/jama.257.15.2070 3560383
11. Tait IA Duthie SJ Taylor-Robinson D Silent upper genital tract chlamydia infection and disease in women Int J STD AIDS 1997, 8:329-331. 10.1258/ 0956462971920037 9175656
12. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. Centers for Disease Control and Prevention. MMWR Recomm Rep 1993, 42(RR-12):1-39. 8418395
13. Rees E The treatment of pelvic inflammatory disease Am J Obstet Gynecol 1980, 138:1042-1047. 6894059
14. Douglas JM Jr. Newman D Bolan G Zenilman JM Rogers J Rhodes F Kamb M Peterman T Low rate of pelvic inflammatory disease (PID) among women with incident Chlamydia trachomatis (CT) infection Int J STD AIDS 2001, 12:65-67. 10.1258/0956462011916659
15. Haddix AC Hillis SD Kassler WJ The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women Sex Transm Dis 1995, 22:274-280. 7502180
16. Wiesenfeld HC Hillier SL Krohn MA Amortegui AJ Heine RP Landers DV Sweet RL Lower genital tract infection and endometritis: Insight into subclinical pelvic inflammatory disease Obstet Gynecol 2002, 100:456-463. 10.1016/S0029-7844(02)02118-X 12220764
17. Hook EW III Spitters C Reichart CA Neumann TM Quinn TC Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening JAMA 1994, 272:867-870. 10.1001/jama.272.11.867 8078164
18. Bachmann L Richey CM Waites K Schwebke JR Hook EW III Patterns of Chlamydia trachomatis testing and follow-up at a university hospital medical center Sex Transm Dis 1999, 26:496-499. 10.1097/ 00007435-199910000-00002 10534201
19. Westrom L Eschenbach D Pelvic inflammatory disease Sexually Transmitted Diseases New York, McGraw-Hill Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P and Wasserheit JN Third 1999, 58:783-809.
20. Gutman LT Gonococcal diseases in infants and children Sexually Transmitted Diseases New York, McGraw-Hill Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P and Wasserheit JN Third 1999, 82:1145-1153.
21. Marrazzo JM Celum CL White C Handsfield HH Cost-effectiveness of urine-based screening for Chlamydia trachomatis with ligase chain reaction in asymptomatic males Proceedings of the 13th Meeting of the International Society for Sexually Transmitted Disease Research Denver, CO 1999
22. Magid D Douglas JM Jr. Schwartz JS Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: An incremental cost-effectiveness analysis Ann Int Med 1996, 124:389-399. 8554247
23. Rein DB Kassler WJ Irwin KL Rabiee L Direct medical cost of pelvic inflammatory disease and its sequelae: Decreasing, but still substantial Obstet Gynecol 2000, 95:397-402. 10.1016/S0029-7844(99)00551-7 10711551
24. Yeh JM Hook EW III Goldie SJ A refined estimate of the average lifetime cost of pelvic inflammatory disease Sex Transm Dis 2003, 30:369-378. 10.1097/00007435-200305000-00001 12916126
25. Rein DB Gift TL A refined estimate of the lifetime cost of pelvic inflammatory disease Sex Transm Dis 2004, 31:325. 10.1097/ 00007435-200405000-00013 15107638
26. Gift TL Owens CJ The direct medical cost of epididymitis and orchitis: Evidence from a study of insurance claims Sex Transm Dis 2006, 33:S84-S88. 10.1097/01.olq.0000235149.41948.fa 17003682
27. Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines, 2006 MMWR Recomm Rep 2006, 55:1-94.
28. Wasserheit JN Valdiserri RO Wood RW Assessment of STD/HIV prevention programs in the United States: National, local, and community perspectives Sexually Transmitted Diseases New York, McGraw-Hill Holmes KK, Sparling PF, Mardh P, Lemon SE, Stamm WE, Piot P and Wasserheit JN Third 1999, 90:1255-1271.
29. Singh AE Romanowski B Syphilis: Review with emphasis on clinical, epidemiologic, and some biologic features Clin Microbiol Rev 1999, 12:187-209. 88914 10194456
30. Landers DV Wiesenfeld HC Heine RP Krohn MA Hillier SL Predictive value of the clinical diagnosis of lower genital tract infection in women Am J Obstet Gynecol 2004, 190:1004-1010. 10.1016/j.ajog.2004.02.015 15118630
31. Finelli L Nakashima AK Hillis S Crayne E Spitalny KC Selective screening versus presumptive treatment criteria for identification of women with chlamydial infection in public clinics: New Jersey Am J Obstet Gynecol 1996, 174:1527-1533. 10.1016/S0002-9378(96)70601-4 9065124
32. Ryan CA Courtois BN Hawes SE Stevens CE Eschenbach DA Holmes KK Risk assessment, symptoms, and signs as predictors of vulvovaginal and cervical infections in an urban US STD clinic: Implications for use of STD algorithms Sex Transm Infect 1998, 74(Suppl 1):S59-S76. 10023355
33. DiCarlo RP Martin DH The clinical diagnosis of genital ulcer disease in men Clin Infect Dis 1997, 25:292-298. 10.1086/514548 9332527
34. Khan A Fortenberry JD Juliar BE Tu W Orr DP Batteiger BE The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment Sex Transm Dis 2005, 32:260-264. 10.1097/01.olq.0000161089.53411.cb 15788928
35. Rothenberg RB Potterat JJ Partner notification for sexually transmitted disease and HIV infection Sexually Transmitted Diseases New York, McGraw-Hill Holmes KK, Sparling PF, Mardh P, Lemon SE, Stamm WE, Piot P and Wasserheit JN Third 1999, 55:745-752.
36. Ruden AK Jonsson A Lidbrink P Allebeck P Bygdeman SM Endemic versus non-endemic gonorrhoea in Stockholm: Results of contact tracing Int J STD AIDS 1993, 4:284-292. 8218516
37. Samoff E Koumans EH Katkowsky S Shouse RL Markowitz LE Contact-tracing outcomes among male syphilis patients in Fulton County, Georgia, 2003 Sex Transm Dis 2007, 34:456-460. 17220811
38. Gunn RA Montes JM Toomey KE Rolfs RT Greenspan JR Spitters CE Waterman SH Syphilis in San Diego County 1983-1992: Crack cocaine, prostitution, and the limitations of partner notification Sex Transm Dis 1995, 22:60-66. 7709327
39. Engelgau MM Woernle CH Rolfs RT Greenspan JR O'Cain M Gorsky RD Control of epidemic early syphilis: The results of an intervention campaign using social networks Sex Transm Dis 1995, 22:203-209. 7482101
40. Sparling PF Natural history of syphilis Sexually Transmitted Diseases New York, McGraw-Hill Holmes KK, Sparling PF, Mardh P, Lemon SE, Stamm WE, Piot P and Wasserheit JN Third 1999, 34:473-478.
41. Schroeter AL Turner RH Lucas JB Brown WJ Therapy for incubating syphilis. Effectiveness of gonorrhea treatment JAMA 1971, 218:711-713. 10.1001/jama.218.5.711 5171497
42. Lyss SB Kamb ML Peterman TA Moran JS Newman DR Bolan G Douglas JM Jr. Iatesta M Malotte CK Zenilman JM Ehret J Gaydos C Newhall WJ Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States Ann Intern Med 2003, 139:178-185. 12899585
43. Creighton S Tenant-Flowers M Taylor CB Miller R Low N Co-infection with gonorrhoea and chlamydia: How much is there and what does it mean? Int J STD AIDS 2003, 14:109-113. 10.1258/095646203321156872 12662389
44. Levitt MA Johnson S Engelstad L Montana R Stewart S Clinical management of chlamydia and gonorrhea infection in a county teaching emergency department--concerns in overtreatment, undertreatment, and follow-up treatment success J Emerg Med 2003, 25:7-11. 10.1016/ S0736-4679(03)00131-8 12865101
45. Lifson AR Halcon LL Hannan P St LME Hayman CR Screening for sexually transmitted infections among economically disadvantaged youth in a national job training program J Adolesc Health 2001, 28:190-196. 10.1016/ S1054-139X(00)00165-8 11226841
46. Miller WC Ford CA Morris M Handcock MS Schmitz JL Hobbs MM Cohen MS Harris KM Udry JR Prevalence of chlamydial and gonococcal infections among young adults in the United States JAMA 2004. 291:2229-2236. 10.1001/jama.291.18.2229 15138245
47. Bachmann LH Pigott D Desmond R Jones M Lumpkins J Gala P Terndrup T Hook EW III Prevalence and factors associated with gonorrhea and chlamydial infection in at-risk females presenting to an urban emergency department Sex Transm Dis 2003, 30:335-339. 10.1097/00007435-200304000-00012 12671555
48. Nsuami M Cammarata CL Brooks BN Taylor SN Martin DH Chlamydia and gonorrhea co-occurrence in a high school population Sex Transm Dis 2004, 31:424-427. 10.1097/01.OLQ.0000130535.96576.D3 15215698
49. Dicker LW Mosure DJ Berman SM Levine WC Gonorrhea prevalence and coinfection with chlamydia in women in the United States, 2000 Sex Transm Dis 2003, 30;472-476. 10.1097/00007435-200305000-00016 12916141
50. Whittington WL Kent C Kissinger P Oh MK Fortenberry JD Hillis SE Litchfield B Bolan GA St Louis ME Farley TA Handsfield HH Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: Results of a multicenter cohort study Sex Transm Dis 2001, 28:117-123. 10.1097/00007435-200102000-00011 11234786
51. Richey CM Macaluso M Hook EW Determinants of reinfection with Chlamydia trachomatis Sex Transm Dis 1999, 26:4-11. 10.1097/ 00007435-199901000-00002 9918317
52. Bernstein KT Zenilman J Olthoff G Marsiglia VC Erbelding EJ Gonorrhea reinfection among sexually transmitted disease clinic attendees in Baltimore, Maryland Sex Transm Dis 2006, 33:80-86. 10.1097/ 01.olq.0000187233.53622.8a 16432478
53. Schillinger JA Kissinger P Calvet H Whittington WL Ransom RL Sternberg MR Berman SM Kent CK Martin DH Oh MK Handsfield HH Bolan G Markowitz LE Fortenberry JD Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: A randomized, controlled trial Sex Transm Dis 2003, 30:49-56. 10.1097/ 00007435-200301000-00011 12514443
54. Golden MR Whittington WL Handsfield HH Hughes JP Stamm WE Hogben M Clark A Malinski C Helmers JR Thomas KK Holmes KK Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection N Engl J Med 2005, 352:676-685. 10.1056/ NEJMoa041681 15716561
55. Chamot E Coughlin SS Farley TA Rice JC Gonorrhea incidence and HIV testing and counseling among adolescents and young adults seen at a clinic for sexually transmitted diseases AIDS 1999, 13:971-979. 10.1097/ 00002030-199905280-00014 10371179
56. Ellen JM Hessol NA Kohn RP Bolan GA An investigation of geographic clustering of repeat cases of gonorrhea and chlamydial infection in San Francisco, 1989-1993: Evidence for core groups J Infect Dis 1997, 175:1519-1522. 9180198
57. Fortenberry JD Brizendine EJ Katz BP Wools KK Blythe MJ Orr DP Subsequent sexually transmitted infections among adolescent women with genital infection due to Chlamydia trachomatis, Neisseria gonorrhoeae, or Trichomonas vaginalis Sex Transm Dis 1999, 26:26-32. 10.1097/ 00007435-199901000-00005 9918320
58. Gunn RA Maroufi A Fox KK Berman SM Surveillance for repeat gonorrhea infection, San Diego, California, 1995-2001: Establishing definitions and methods Sex Transm Dis 2004, 31:373-379. 10.1097/ 00007435-200406000-00011 15167649
59. Gunn RA Fitzgerald S Aral SO Sexually transmitted disease clinic clients at risk for subsequent gonorrhea and chlamydia infections: Possible 'core' transmitters Sex Transm Dis 2000, 27:343-349. 10.1097/ 00007435-200007000-00008 10907910
60. Oh MK Cloud GA Fleenor M Sturdevant MS Nesmith JD Feinstein RA Risk for gonococcal and chlamydial cervicitis in adolescent females: Incidence and recurrence in a prospective cohort study J Adolesc Health 1996, 18:270-275. 10.1016/1054-139X(95)00232-H 8860791
61. Orr DP Johnston K Brizendine E Katz B Fortenberry JD Subsequent sexually transmitted infection in urban adolescents and young adults Arch Pediatr Adolesc Med 2001, 155:947-953. 11483124
62. Thomas JC Weiner DH Schoenbach VJ Earp JA Frequent re-infection in a community with hyperendemic gonorrhoea and chlamydia: Appropriate clinical actions Int J STD AIDS 2000, 11:461-467. 10.1258/ 0956462001916254 10919489
63. Radolf JD Sanchez PJ Schulz KF Murphy FK Congenital syphilis Sexually Transmitted Diseases New York, McGraw-Hill Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P and Wasserheit JN Third 1999, 84:1165-1189.
64. de Lissovoy G Zenilman J Nelson KE Ahmed F Celentano DD The cost of a preventable disease: Estimated U.S. national medical expenditures for congenital syphilis, 1990 Public Health Rep 1995, 110:403-409. 1382149 7638327
65. Bateman DA Phibbs CS Joyce T Heagarty MC The hospital cost of congenital syphilis J Pediatr 1997, 130:752-758. 10.1016/S0022-3476(97)80018-2 9152285
66. Welte R Postma M Leidl R Kretzschmar M Costs and effects of chlamydial screening: Dynamic versus static modeling Sex Transm Dis 2005, 32:474-483. 10.1097/01.olq.0000161181.48687.cf 16041248
67. Pinkerton SD Holtgrave DR Johnson-Masotti AP Turk ME Hackl KL DiFranceisco W NIMH Multisite HIV Prevention Trial Group Cost-effectiveness of the NIMH multisite HIV prevention intervention AIDS Behav 2002, 6:83-96. 10.1023/A:1014532713594
68. Wasserheit JN Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases Sex Transm Dis 1992, 19:61-77. 1595015
69. Grosskurth H Mosha F Todd J Mwijarubi E Klokke A Senkoro K Mayaud P Changalucha J Nicoll A Kagina G Newell J Mugeye K Mabey D Hayes R Impact of Improved Treatment of Sexually-Transmitted Diseases on Hiv-Infection in Rural Tanzania - Randomized Controlled Trial Lancet 1995, 346:530-536. 10.1016/S0140-6736(95)91380-7 7658778
70. Chesson HW Pinkerton SD Sexually transmitted diseases and the increased risk for HIV transmission: Implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions J Acquir Immune Defic Syndr 2000, 24:48-56. 10877495
71. Kerani RP Handsfield HH Stenger MS Shafii T Zick E Brewer D Golden MR Rising rates of syphilis in the era of syphilis elimination Sex Transm Dis 2007, 34:154-161. 10.1097/01.olq.0000233709.93891.e5 17179773
72. Buchacz K Greenberg A Onorato I Janssen R Syphilis epidemics and human immunodeficiency virus (HIV) incidence among men who have sex with men in the United States: Implications for HIV prevention Sex Transm Dis 2005, 32:S73-S79. 10.1097/01.olq.0000180466.62579.4b 16205297
73. Hogben M Paffel J Broussard D Wolf W Kenney K Rubin S George D Samoff E Syphilis partner notification with men who have sex with men: A review and commentary Sex Transm Dis 2005, 32:S43-S47. 10.1097/ 01.olq.0000180565.54023.bf 16205292
74. Paz-Bailey G Meyers A Blank S Brown J Rubin S Braxton J Zaidi A Schafzin J Weigl S Markowitz LE A case-control study of syphilis among men who have sex with men in New York City: Association with HIV infection Sex Transm Dis 2004, 31:581-587. 15388994
75. Taylor M Aynalem G Smith L Bemis C Kenney K Kerndt P Correlates of Internet use to meet sex partners among men who have sex with men diagnosed with early syphilis in Los Angeles County Sex Transm Dis 2004, 31:552-556. 10.1097/01.olq.0000137902.71284.b0 15480117
76. Pinkerton SD Chesson HW Holtgrave DR Kassler W Layde PM When is an HIV infection prevented and when is it merely delayed? Eval Rev 2000, 24:251-271. 10947517
77. Truong HHM Kellogg T Klausner JD Katz MH Dilley J Knapper K Chen S Prabhu R Grant RM Louie B McFarland W Increases in sexually transmitted infections and sexual risk behaviour without a concurrent increase in HIV incidence among men who have sex with men in San Francisco: A suggestion of HIV serosorting? Sex Transm Infect 2006, 82:461-466. 10.1136/sti.2006.019950 17151031
78. Varghese B Peterman TA Holtgrave DR Cost-effectiveness of counseling and testing and partner notification: A decision analysis AIDS 1999, 13:1745-1751. 10.1097/00002030-199909100-00019 10509577
79. Paltiel AD Weinstein MC Kimmel AD Seage GR III Losina E Zhang H Freedberg KA Walensky RP Expanded screening for HIV in the United States--an analysis of cost-effectiveness N Engl J Med 2005, 352:586-595. 10.1056/NEJMsa042088 15703423
80. Sanders GD Bayoumi AM Sundaram V Bilir SP Neukermans CP Rydzak CE Douglass LR Lazzeroni LC Holodniy M Owens DK Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy N Engl J Med 2005, 352:570-585. 10.1056/NEJMsa042657 15703422
81. Cohen DA Wu SY Farley TA Comparing the cost-effectiveness of HIV prevention interventions J Acquir Immune Defic Syndr 2004, 37:1404-1414. 10.1097/01.qai.0000123271.76723.96 15483470
82. MacKellar DA Valleroy LA Secura GM Bartholow BN McFarland W Shehan D Ford W LaLota M Celentano DD Koblin BA Torian LV Perdue TE Janssen RS Repeat HIV testing, risk behaviors, and HIV seroconversion among young men who have sex with men: A call to monitor and improve the practice of prevention J Acquir Immune Defic Syndr 2002, 29:76-85. 11782594
83. Centers for Disease Control and Prevention HIV counseling and testing in publicly funded sites: Annual report 1997 and 1998 Atlanta GA, Centers for Disease Control and Prevention 2001
84. Priddy FH Pilcher CD Moore RH Tambe P Park MN Fiscus SA Feinberg MB del RC Detection of acute HIV infections in an urban HIV counseling and testing population in the United States J Acquir Immune Defic Syndr 2007, 44:196-202. 10.1097/01.qai.0000254323.86897.36 17312561
85. Blandford JM Gift TL Productivity losses attributable to untreated chlamydial infection and associated pelvic inflammatory disease in reproductive-aged women Sex Transm Dis 2006, 33:S117-S121. 10.1097/ 01.olq.0000235148.64274.2f 17003678
86. Institute of Medicine (Committee on Prevention and Control of Sexually Transmitted Diseases) The Hidden Epidemic: Confronting Sexually Transmitted Diseases Washington, D.C, National Academy Press Eng TR and Butler WT 1997
87. Doubilet P Begg CB Weinstein MC Braun P McNeil BJ Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach Medical Decision Making 1985, 5:157-177. 10.1177/0272989X8500500205 3831638
88. Heffelfinger JD Swint EB Berman SM Weinstock HS Trends in primary and secondary syphilis among men who have sex with men in the United States Am J Public Health 2007, 97:1076-1083. 10.2105/AJPH.2005.070417 17463387
89. Martin JA Hamilton BE Sutton PD Ventura SJ Menacker F Kirmeyer S Births: final data for 2004 Natl Vital Stat Rep 2006, 55:1-101.
90. Low N Egger M Sterne JA Harbord RM Ibrahim F Lindblom B Herrmann B Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: The Uppsala Women's Cohort Study Sex Transm Infect 2006, 82:212-218. 10.1136/sti.2005.017186 16731670
91. Garnett GP An introduction to mathematical models in sexually transmitted disease epidemiology Sex Transm Infect 2002, 78:7-12. 1763694 11872850 10.1136/sti.78.1.7
92. Centers for Disease Control and Prevention Sexually Transmitted Disease Surveillance, 2005 Atlanta, U.S. Department of Health and Human Services 2006
93. Blocker ME Levine WC St Louis ME HIV prevalence in patients with syphilis, United States Sex Transm Dis 2000, 27:53-59. 10.1097/ 00007435-200001000-00011 10654870
94. Stray-Pedersen B Economic evaluation of maternal screening to prevent congenital syphilis Sex Transm Dis 1983, 10:167-172. 6665662
95. Silberstein GS Coles FB Greenberg A Singer L Voigt R Effectiveness and cost-benefit of enhancements to a syphilis screening and treatment program at a county jail Sex Transm Dis 2000, 27:508-517. 10.1097/ 00007435-200010000-00004 11034525